Top compounds associated with response to CTD-3105H18.16


Feature Type Standardized
Nominal ANOVA
mRNA tigecycline CTRPv2 pan-cancer AAC 0.054 0.3
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.042 0.3
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.091 0.3
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.04 0.3
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.046 0.3
mRNA HLI 373 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
Download CSV